Company / Current Liabilities per Share
ArriVent BioPharma, Inc. Current Liabilities per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.55
FY2024
5-year range
$0.55 / $5.43
FY2023-FY2024
Trend
-89.9%
vs FY2023
Sector context
#151 of 210
Health Care
What the data says
At $0.55, ArriVent BioPharma, Inc.'s current liabilities per share ranks #60 of 210 in the Health Care sector.
Based on SEC 10-K filings.
0.55 in FY2024.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 210 in Health CareTop 28% of 210This company $0.55 Sector average $23.79
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 89.9% year-over-year.
- Ranks #151 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.55 | -89.9% |
| FY2023 | $5.43 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026